T1	Participants 197 340	86 pediatric and adult patients (41 Haemophilus influenzae, 22 Streptococcus pneumoniae, 13 Neisseria meningitidis, and 10 of unknown etiology)
T2	Participants 734 790	patients with CSF protein concentrations >/=75 mg/100 ml
T3	Participants 882 971	8 had significant residua and 3 died; among CB patients (41), 5 had residua and none died
T4	Participants 982 1149	38% of H. influenzae patients treated with CB had positive CSF cultures on day 1 follow-up lumbar punctures, compared with only 5.8% of AMP patients with H. influenzae
